Invention Grant
US07985753B2 Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators
失效
取代的吡唑并[1,5-A]嘧啶作为代谢型谷氨酸受体调节剂
- Patent Title: Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators
- Patent Title (中): 取代的吡唑并[1,5-A]嘧啶作为代谢型谷氨酸受体调节剂
-
Application No.: US11890199Application Date: 2007-08-03
-
Publication No.: US07985753B2Publication Date: 2011-07-26
- Inventor: Wojciech Danysz , Andrzej Dekundy , Mirko Hechenberger , Markus Henrich , Claudia Jatzke , Jens Nagel , Christopher Graham Raphael Parsons , Tanja Weil , Juris Fotins , Aleksandrs Gutcaits , Ivars Kalvinsh , Ronalds Zemribo , Valerjans Kauss
- Applicant: Wojciech Danysz , Andrzej Dekundy , Mirko Hechenberger , Markus Henrich , Claudia Jatzke , Jens Nagel , Christopher Graham Raphael Parsons , Tanja Weil , Juris Fotins , Aleksandrs Gutcaits , Ivars Kalvinsh , Ronalds Zemribo , Valerjans Kauss
- Applicant Address: DE Frankfurt am Main
- Assignee: MERZ PHARMA GmbH & Co. KGaA
- Current Assignee: MERZ PHARMA GmbH & Co. KGaA
- Current Assignee Address: DE Frankfurt am Main
- Agency: Hueschen and Sage
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61P25/28 ; A61P25/02 ; A61P35/00 ; A61P25/22
![Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators](/abs-image/US/2011/07/26/US07985753B2/abs.jpg.150x150.jpg)
Abstract:
Substituted pyrazolopyrimidine derivatives of formula (I) wherein Y1, Y2, Y3, Y4 represent N or C—, whereby at least two of the groups Y1 to Y4 represent a carbon atom, R1 represents chloro or bromo, R2 to R7 represent e.g. hydrogen, methyl or ethyl; and R10 and R11 independently represent e.g. hydrogen or C1-C6alkyl, are potent mGluR5 modulators and are useful for the prevention of acute and chronic neurological disorders.
Public/Granted literature
- US20080039458A1 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine Public/Granted day:2008-02-14
Information query